A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease
Public ClinicalTrials.gov record NCT02353598. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase Ib, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Arm, Multiple-Dose Study to Assess The Safety, Tolerability, And Pharmacokinetics of Intravenous Crenezumab Administered in Patients With Mild to Moderate Alzheimer's Disease
Study identification
- NCT ID
- NCT02353598
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Genentech, Inc.
- Industry
- Enrollment
- 77 participants
Conditions and interventions
Conditions
Interventions
- Crenezumab dose level 1 Drug
- Crenezumab dose level 2 Drug
- Crenezumb dose level 3 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 25, 2015
- Primary completion
- Nov 29, 2016
- Completion
- Mar 25, 2019
- Last update posted
- Jul 23, 2019
2015 – 2019
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Scottsdale | Phoenix | Arizona | 85054 | — |
| UCSF - Memory and Aging Center | San Francisco | California | 94158 | — |
| Brain Matters Research, Inc. | Delray Beach | Florida | 33445 | — |
| Miami Jewish Health Systems | Miami | Florida | 33137 | — |
| Bioclinica Orlando | Orlando | Florida | 32806 | — |
| Bioclinica The Villages | The Villages | Florida | 32162 | — |
| Indiana University School Of Medicine; Department Of Neurology | Indianapolis | Indiana | 46202 | — |
| Hattiesburg Clinic | Hattiesburg | Mississippi | 39401 | — |
| Millennium Psychiatric Associates, LLC | St Louis | Missouri | 63132 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| UNiversity of Rochester | Rochester | New York | 14620 | — |
| Rhode Island Mood & Memory Research Institute | East Providence | Rhode Island | 02914 | — |
| Roper St. Francis Healthcare; Clinical Biotechnology Research Institute | Charleston | South Carolina | 29401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02353598, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 23, 2019 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02353598 live on ClinicalTrials.gov.